Ultrastructure imaging of Pseudomonas aeruginosa lawn biofilms and eradication of the tobramycin-resistant variants under in vitro electroceutical treatment

Abstract

Electrochemically generated bactericidal compounds have been shown to eradicate bacterial lawn biofilms through electroceutical treatment. However, the ultrastructure of biofilms exposed to these species has not been studied. Moreover, it is unknown if the efficacy of electroceutical treatment extends to antibiotic-resistant variants that emerge in lawn biofilms after antibiotic treatment. In this report, the efficacy of the in vitro electroceutical treatment of Pseudomonas aeruginosa biofilms is demonstrated both at room temperature and in an incubator, with a ~4 log decrease (p < 0.01) in the biofilm viability observed over the anode at both conditions. The ultrastructure changes in the lawn biofilms imaged using transmission electron microscopy demonstrate significant bacterial cell damage over the anode after 24 h of electroceutical treatment. A mix of both damaged and undamaged cells was observed over the cathode. Finally, both eradication and prevention of the emergence of tobramycin-resistant variants were demonstrated by combining antibiotic treatment with electroceutical treatment on the lawn biofilms.

Introduction

Biofilms are structured aggregates of bacteria embedded in self-produced extracellular polymeric substances (EPS) including proteins, DNA, and polysaccharides1,2. Biofilms on or embedded in living tissues, such as wounds, can cause chronic infections that may be resistant to killing by systemic antibiotics, topical antiseptics, and the host immune system3,4. Biofilms usually present a persistent pathology4,5,6. For instance, chronically infected wounds are generally non-healing3,6 and affect over 6.5 million individuals in the US alone with an estimated ~\$25 billion spent annually on healthcare costs6.

We recently reported on the screen-printed silver/silver chloride (Ag/AgCl) wound dressings called electroceuticals7, which are conformable to the wound morphology and present an emerging paradigm for the treatment of open, chronic, and biofilm-infected wounds. Past work has shown that electrochemical treatment by electroceuticals eradicates or inhibits the growth of both planktonic bacteria and bacterial biofilms8,9,10,11,12. However, the use of electroceuticals under different treatment conditions and the impact of these electrochemical treatments on the biofilm ultrastructure, which is defined as the detailed structure of bacterial cells including sub-cellular structures and the structure of the cell envelope, is not well understood. Furthermore, it is unknown if the treatment efficacy of electrochemically generated bactericidal species extends to the antibiotic-resistant variants that have been shown to emerge after standard antibiotic treatment of biofilms13.

In this paper, we address these knowledge gaps using in vitro electrochemical treatment on Pseudomonas aeruginosa (PA) lawn biofilms and the emergent antibiotic-resistant variants. Notably, PA is one of the most common nosocomial pathogens isolated from chronic wound infections14,15. PA infections are treated using clinically relevant antibiotics such as tobramycin16,17. However, PA exhibits resistance to multiple antimicrobial agents due to its genome that encodes for antibiotic inactivating enzymes and multi-drug efflux pumps15,18. PA biofilms express drug-tolerant persister cells and drug-resistant variants that can survive aggressive antibiotic treatments, host immune defenses, and present a persistent pathology14,15. Moreover, the antibiotic resistance in a biofilm can be 1000-fold larger than the planktonic bacteria19,20.

Previous in vitro work on the electrochemical treatment of bacteria has shown that bacterial eradication spans a large range of electrode materials — silver (Ag), platinum (Pt), gold (Au), stainless steel, and copper (Cu)8. The bacterial eradication was observed over a broad direct current (dc) range, reported as current density, from ~ 0.02 to 20.00 µA/mm2 for treatment of Staphylococcus aureus, Escherichia coli, Proteus vulgaris, and Pseudomonas aeruginosa (PA)8. At the highest current density of ~20.00 µA/mm2, all electrode materials inhibited bacterial growth at both the anode and the cathode8; however, Ag anodes also showed inhibition at the lowest current density levels of 0.02 µA/mm2 with minimal inhibition at the Ag cathodes. Furthermore, electrochemical treatments in vivo of PA infected wounds in rabbits with Cu mesh electrodes also exhibited infection clearance21.

Mechanistically, for Pt electrodes, electrochemically generated hypochlorous acid (HOCl), which is a reactive chlorine species (RCS)22, was considered responsible for bactericidal effects observed on Staphylococcus epidermidis biofilms grown on polycarbonate disks under physiological saline conditions23. Further, cathodic polarization of Pt coupons (−1.5 V and −1.8 V vs. Ag/AgCl) incubated in cultures of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii showed reduced bacterial attachment and viability24. Sultana et. al. demonstrated that electrochemically generated hydrogen peroxide (H2O2), a reactive oxygen species (ROS)22, increased the tobramycin susceptibility in PA biofilms11. The electrochemical scaffold (or e-scaffold) made with a conductive carbon fabric11 was polarized at a constant potential against standard Ag/AgCl reference electrodes for production of H2O2. The e-scaffold was also recently used to generate HOCl for the treatment of in vitro biofilms25. Dusane et al.26 reported an innovative soft-tissue infection in vitro assay. In their work, Dusane et al. showed the electroceutical eradication of a 24-hour grown lawn biofilm of bioluminescent Pseudomonas aeruginosa Xen 41 (PA-Xen41) using Ag electrodes embedded in nutrient agar. HOCl and other derived reaction products such as chloramines were reported as the likely species for observed bactericidal effects26.

Despite growing evidence for ROS and RCS being the anti-bacterial agents in the electrochemical treatment of biofilms, the effect of these bactericidal species on biofilm ultrastructure at any of the electrical poles i.e., the anode or the cathode is unknown. Furthermore, there are no systematic reports with a reliable investigation of the treatment efficacy of electrochemically generated bactericidal species at different treatment conditions, including when the antibiotic-resistant variants emerge from a lawn biofilm after the application of a standard antibiotic treatment13.

In this report, the electroceutical treatment of PA-Xen41 lawn biofilms was assessed by time-lapse quantification of biofilm viability and bacterial luciferase activity maps, both at room temperature (~25 °C) under ambient laboratory conditions, and in an incubator (temperature, T = 37 °C and 5% CO2 concentration). Next, the effects of electrochemically generated bactericidal species on the ultrastructure of the lawn biofilms were observed using transmission electron microscopy (TEM) for both the anode and cathode at select time intervals over a 24-hour treatment period. Finally, we evaluated the combined antibiotic and electroceutical treatment of tobramycin-resistant phenotypes that emerge from the PA lawn biofilms after standard tobramycin treatment.

Methods

Agar based tissue model and quantification of biofilm viability

A bioluminescent strain of Pseudomonas aeruginosa (or PA-Xen41) (PerkinElmer, USA) was used in all experiments with culture methods and conditions reported previously26. The development and use of the agar-based in vitro tissue model (Fig. 1a) for electroceutical treatment of the lawn biofilms was also recently reported26. Briefly, sterilized Ag foil electrodes (0.1 mm thick, 99.9% purity, Sigma-Aldrich, USA) were placed in a petri dish (150 mm outer diameter, Fisher Scientific, USA). The Ag electrodes were 80 mm long × 3 mm wide with 3 cm spacing between the electrodes. Sterilized 55 mL tryptic soy agar (TSA), containing 1.5% (w/v) agar (Fisher Scientific, USA) prepared with 3% (w/v) tryptic soy broth (TSB, Sigma Aldrich, USA) was poured over the electrodes and cooled aseptically to form a gel (≈3.6 mm thick) at room temperature (RT). Next, 100 µL of an overnight culture of PA-Xen41 grown in TSB was diluted with 9.9 mL TSB to prepare the inoculum. 400 µL of this inoculum was spread on the surface of the TSA gel using a sterile glass spreader. The petri dishes were then cultured for 24 h at 37 °C and 5% CO2 in a humidified incubator (Heracell 150i, Thermo Scientific)26. It has been previously shown that these bacterial lawns exhibit phenotypic characteristics of biofilms, and therefore, they are typically referred to as lawn biofilms26,27.

The electroceutical treatment of PA-Xen41 lawn biofilms (Fig. 1a) was started after 24 h of biofilm growth marked as t = 0 h, where t is the treatment time. The electroceutical treatment was applied i.e., current was ‘on’ until t = 24 h. As previously reported26, a portable battery (two 3 V Lithium cells in series, CR2032 Energizer) with a nominal voltage of 6 V was used as a DC power source and a ballast resistor of 1 kΩ was used to limit the current flow. The current at the beginning of the treatment was typically ~3.5 mA and reduces to ~100 μA at t = 24 h with the growth of AgCl layer on the anode, while complete experimental details were reported previously26. The protocols for obtaining colony-forming units and bacterial luciferase activity maps through in vivo imaging system or IVIS (Xenogen IVIS 100, Hopkinton, USA) imaging have been reported previously26. Briefly, IVIS imaging is used as a large field of view, with length scales on the order of 10 cm, optical imaging modality for qualitative monitoring of the metabolic activity and the growth of bioluminescent reporters26,28. PA-Xen 41 expresses luciferase bioluminescence, which is captured by Xenogen IVIS 100 using a back-illuminated charged coupled device (CCD) camera.

pH measurement

Quantitative pH measurements at ~2 mm immersion depth from the surface of the TSA using a pH microelectrode per vendor specifications (Microelectrodes Inc., USA) are reported. The pH measurements were directly over anode, cathode, and at least 2 cm away from both electrodes to serve as an internal control. pH measurements from three different sets of experiments and mean ± standard deviations are reported.

Imaging biofilm microstructure and ultrastructure

Transmission Electron Microscopy was used to assess changes in bacterial cell ultrastructure due to the electroceutical treatment. Lawn biofilm samples on agar were obtained by using a 3 mm diameter punch from the anode, cathode, and control (i.e., from lawn biofilms where electroceutical treatment was not applied). These plugs were also used for quantifying viable cells as colony-forming units (CFUs). The punched samples (i.e., biofilm on ≈ 3.6 mm underlying TSA) were fixed in 2.5% glutaraldehyde (25% EM grade, #18426 Ted Pella, Inc.) in 0.1 M phosphate buffer solution (PBS at pH = 7.4) overnight at 4 °C. After fixation, the samples were rinsed twice for ten minutes each in 0.1 M PBS, and subsequently, stained with 1% osmium tetroxide (#18456 Ted Pella, Inc.) in 0.1 M PBS for 2 h at RT. The samples were then rinsed twice for five minutes each in water and then stained in 1% uranyl acetate (ACS grade, #19481, Ted Pella, Inc.) for 1 h at RT. Next, the samples were dehydrated in a graded ethanol (190 proof, #2805HC Decon Labs, Inc.) series diluted with distilled water for the following concentration sequence: 50% ×2, 70% ×2, 80% ×2, 95% ×2 with each dehydration step being 10 minutes long. The dehydration step was completed with the final two changes of 100% ethanol (200 proof) for 15 minutes each and two changes of acetone (HPLC Grade, #A949-4 Fisher Scientific) for 15 minutes each. The samples were infiltrated with a series of Eponate 12 (Ted Pella, Inc.) epoxy resin and acetone according to the following scheduled steps: (a) 1:1 of resin mix: acetone for 2 h, (b) 2:1 resin mix: acetone for 3 h, (c) 100% resin mix for 3 h, (d) another 100% resin mix for 3 h. The samples were then moved to freshly made resin mix in a silicone mold and the resin was cured in an oven at 60 °C for 48 h. The resin blocks with embedded gel and biofilm samples were then manually trimmed with a razor blade, and the samples were sectioned on an ultramicrotome (Leica UC6) using a diamond knife (Diatome) with a 6° clearance angle in 90 nm thick sections. Finally, 90 nm thick sections were stained with 1% aqueous uranyl acetate for 3 minutes followed by 2 minutes in lead citrate (EM Grade, #19314 Ted Pella, Inc.). The samples were observed using FEI Tecnai G2 Spirit TEM at 80 kV. The TEM images were captured with an Advanced Microscopy Techniques camera.

Combining antibiotic and electroceutical treatments

To expose the lawn biofilms to a combination of antibiotic and electroceutical treatments, a modified Kirby-Bauer method was used13. In this method, blank paper disks (6 mm diameter, Remel Blank Paper Disk, Thermo Fisher Scientific) loaded with 100 µg tobramycin (TOB), delivered in a 10 µL drop and allowed to dry, were used. Three such antibiotic-loaded disks were placed over 24 h PA-Xen41 lawn biofilms. The disks were equidistant from each other and the periphery of the petri dish (140 mm inner diameter). The positions of the disks (one at the center of the petri dish and two placed at 35 mm away from the center disk on each side, i.e., towards the anode and the cathode) were marked using a Vernier caliper on the petri dishes before the start of the experiments (Fig. S1). Two separate experiments were performed after the placement of TOB loaded disks (marked as time, t = 0 h): one for observing the effects of electroceutical treatment on TOB-resistant variants which grow in the cleared zone after extended incubations in the presence of antibiotics29 and the other for evaluating if the electroceutical treatment can prevent the emergence of TOB-resistant variants.

Treatment of antibiotic-resistant variants in PA-Xen41 lawn biofilms

TOB loaded paper disks were placed over the 24 h grown PA-Xen41 lawn biofilm at t = 0 h, which was incubated at 37 °C and 5% CO2 until t = 72 h. The antibiotic-resistant phenotypes emerge in the cleared lawn at t = 72 h in IVIS imaging13. After emergence of the antibiotic-resistant phenotypes, electroceutical treatment was applied for an additional 24 h (i.e., from t = 72 h to t = 96 h). The response of the antibiotic-resistant phenotypes to treatment was observed using both IVIS and white light digital imaging.

Prevention of the emergence of antibiotic-resistant variants in PA-Xen41 lawn biofilms

The TOB loaded paper disks were placed on top of the lawn biofilms and the electroceutical treatment was started immediately (i.e., t = 0 h) and continued for 24 h in the 37 °C incubator. After the electroceutical treatment was stopped at t = 24 h, the culture plates continued to be incubated until t = 72 h. IVIS images were recorded every 24 h to observe the metabolic activity maps of PA-Xen41 lawn biofilms in response to the treatment conditions. The extended incubation period was used since the antibiotic-resistant variants of Pseudomonas aeruginosa often have a delayed lag phase or slow growth phenotype13.

Replica plating method

For assessing whether electroceutical treatment was effective against TOB-resistant variants, three regions of interest (Supplementary Information, Fig. S1) were observed in our in vitro assay: (i) the regions primarily impacted by the TOB diffusing from the disks, (ii) the regions over the electrodes alone (primarily the anode in our case), and (iii) the overlapping regions influenced by both the electrode and TOB. Replica plating13 was used to assess whether all bacteria, including antibiotic-resistant variants13,30, were eliminated in these regions of interest (Supplementary Information).

Replica plating13 was performed on the prevention and treatment plates after t = 72 h and t = 96 h respectively by stamping the original plate onto Luria broth (LB) agar plates with and without 5 µg/mL TOB (Supplementary Information, Fig. S1), which is more than minimum inhibitory concentration, MIC, of TOB (1.5 µg/mL) for PA-Xen4113. Briefly, a sterile, cotton velveteen cloth (150 × 150 mm, Scienceware, Sigma-Aldrich, USA) aseptically wrapped and locked using an aluminum ring over a poly(vinyl) chloride replica plater (Scienceware, Sigma-Aldrich, USA) was used for stamping. In this replica plating assay, areas with no growth on the antibiotic-free replica plate show complete elimination of the bacteria in the biofilm (Supplementary Information, Fig. S1 shows both replica plates after 24 h of incubation at 37 °C and 5% CO2). Colonies which grow on both plates, i.e. with and without antibiotic, are TOB-resistant variants. All the replica plates were observed through IVIS imaging.

Statistical analysis

All experiments to compare biofilm viability and luciferase activity between incubator and RT conditions were in triplicates. For multiple comparisons (i.e., between the anode, cathode, and control) with the data, at each time point, t, one-way ANOVA test with post hoc Tukey’s test was performed for determination of statistical significance (p ≤ 0.01). Statistics were performed on log transformed CFU data using MATLAB. The in-built function “anova1” was used to determine group means and variance while the in-built “multcompare” was used for post hoc test. The functional parameters ‘Alpha’ and ‘CType’ were set to 0.01 and ‘tukey-kramer’ respectively, corresponding to the significance level and test type.

Results and Discussion

Effects of electroceutical treatment on PA -Xen41 biofilm

Wound healing is delayed when the wound bed temperature decreases below normal core body temperature (37° C) or rises above 42° C31. Notably, the wound bed temperatures have been reported in a range of 25.3° C − 37.3° C with a mean of ~32.6° C32,33. Furthermore, biofilm growth and structure are known to be affected by environmental conditions34; however, the effect of changing ambient conditions such as temperature or the incubator environment on the electrochemical treatment of PA lawn biofilms has not been previously studied or reported. Therefore, lawn biofilms of PA-Xen41 (Fig. 1a) were subjected to electroceutical treatment for 24 h both at room temperature (RT) and in the incubator (37 °C and 5% CO2) to evaluate electroceutical treatment efficacy over the broad range of clinically relevant conditions7. At both RT and in the incubator, after t = 48 h (i.e., 24 h after treatment was turned off), a ~4-log decrease (p < 0.01) in biofilm viability (colony-forming unit per cm2, CFU/cm2) was observed at the anode compared to control (Fig. 1b,c). A difference of ~3-log (p < 0.01) was also observed at the anode compared to the cathode (Fig. 1b,c) at both RT and in the incubator. However, no significant reduction in biofilm viability was observed (Fig. 1b,c) at the cathode compared to control at any time points (p > 0.05).

At the anode, the zone of inhibition (i.e., zones of low or no metabolic activity) increased in width over the electrodes during the electrochemical treatment both at RT and in the incubator26 (Fig. 2). HOCl has been previously identified26 as the bactericidal agent generated at the anode. The electrochemical characterization of the in vitro set-up is shown in Supplementary Information, Figs. S2S5. Notably, the zones of inhibition were spatially non-uniform over the cathode (Fig. 2a) for the biofilm treated at RT. The observed non-uniformities for bactericidal effects over the cathode compared to the anode are likely due to local conditions, including possible gas bubble entrapment over electrodes (Supplementary Information, Fig. S3), non-uniformities in the agar gels26. The exact mechanistic details for the observed differences are beyond the scope of this work and remain an active topic of investigation for future studies. Nevertheless, the zones of inhibition over the cathode were visibly larger for the biofilm treated at RT than that treated in the incubator for t = 8 h, 24 h, and 48 h.

It is worthwhile to note that the CFU/cm2 data (Fig. 1b,c) only presents a snapshot of the effects of electroceutical treatment over the punch biopsy area and is a ‘region of interest’ result that only captures bacterial eradication if the sampled area was directly impacted electrochemically. Eradication of the biofilm observed at RT was not spatially uniform over the cathode (Fig. 2a), and it is important to note that the biopsy punches (3 mm diameter) were consistently taken at the middle of the electrode, therefore CFU/cm2 might not reflect a complete picture of the bactericidal effects at the cathode due to the electrochemical treatment. However, the electrochemical treatment was effective in the eradication of PA-Xen41 lawn biofilm over the anode (~4-log decrease in biofilm viability) at both RT and incubator conditions.

After 24 h of electroceutical treatment, the pH reported earlier26 at cathode and anode were 8.40 ± 0.1 and 6.71 ± 0.1 respectively for the biofilm treated in the incubator, which agrees with the results reported in Table 1. It was previously reported26 that OH is generated at the cathode, leading to the measured increase in the pH (Table 1) at both RT and in the incubator compared to control. For the biofilm treated at RT, the pH at cathode was 11.46 ± 0.26 at t = 8 h and 9.82 ± 0.26 at t = 24 h, while for the biofilm treated electroceutically at incubator conditions, the pH at the cathode was measured to be 9.33 ± 0.19 at t = 8 h and 8.48 ± 0.18 at t = 24 h. These observations indicate that the higher pH and lower ambient temperature34,35,36 possibly leads to the visibly larger zones of inhibition over the cathode for the biofilm treated at RT (Fig. 2a). Finally, the differences in pH at cathode between RT and the incubator conditions are likely due to the carbonate buffering of CO2 in the incubator.

Ultrastructure changes in the biofilm architecture under electrochemical treatment

Transmission Electron Microscopy (TEM) displays high-resolution images of cellular ultrastructure i.e., the sub-cellular structure and the structure of the cell envelope, as compared to other imaging methods such as scanning electron microscopy that are limited to imaging the topography of microbial communities leaving the underlying sub-cellular structure unexamined37, or optical microscopy which is useful for features with characteristic length scales of a few hundred nanometers and larger. Therefore, ultrastructure changes in PA-Xen41 lawn biofilms were recorded using a TEM at three time points (t = 0, 8, and 24 h) for the electroceutical treatment in the incubator (T = 37 °C; 5% CO2). Figure 3 shows the TEM images before the electroceutical treatment started (i.e., t = 0 h). The TEM images reported here showed non-uniformly packed cells (red square in Fig. 3a) with interstitial ‘void’ spaces (green square in Fig. 3a) similar to images reported previously37. Bacterial cells (examples marked by a circle in Fig. 3b) with expelled cellular content, possibly DNA fibers with images showing structures similar to previously reported images38 (Fig. 3b), were also observed. Finally, normal or intact bacterial cells in the control sample showed two distinct electron densities (lighter and darker gray areas within the cells, Fig. 3c). Past ultrastructure imaging has shown that the cellular DNA could be concentrated in the light gray region which is represented as the low electron density region for TEM imaging38.

Figure 4 shows the ultrastructure images of the control (Fig. 4a–c), anode (Fig. 4d–f), and cathode (Fig. 4g–i) at t = 8 h after the treatment was started. The TEM images with the 2 µm scale (magnification: 6800×) do not show significant differences in cellular morphology between the control (Fig. 4a), anode (Fig. 4d), and cathode (Fig. 4g) regions. Notably, two different morphologies, one similar to normal bacteria as observed at t = 0 h and another where bacterial cells lacked cytoplasmic content (marked by yellow triangles), were observed in control (Fig. 4a–c), anode (Fig. 4d–f), and cathode (Fig. 4g–i) samples.

Note that Fig. 2b shows only small regions of reduced activity under IVIS over the anode at t = 8 h. The differences between this localized region of bacterial inhibition observed using IVIS for the incubator (37 °C) biofilms compared to the observed ultrastructure could be attributed to the fact that the TEM images represent a small area or region of interest imaging, with the field of view length scales on the order of 100 μm or less, on the samples consistently taken over the center of the electrodes using a 3 mm diameter punch (see methods section), and therefore, cannot capture the larger area (~3 mm × 8 cm) over the whole anode imaged using IVIS technology.

Interestingly, the pili or fibril-like structures (Fig. 4c,f,i) were observed on several bacterial cells for control, anode, and cathode samples that were less electron-dense compared to normal cells (Fig. 4b,e,h). These pili or fibril-like structures are marked in Fig. 4c,f,i by yellow arrows. Moreover, such pili or fibril-like structures have not been reported previously for PA lawn biofilms and the appearance of these structures regardless of the electrochemical treatment shows that these may not be an artifact due to the treatment methodology used here. Further work beyond the scope of this paper is needed to assess, identify, and quantify these structures.

Figure 5 shows TEM images for t = 24 h after starting the electroceutical treatment. The control samples (i.e., with no electroceutical treatment) showed white spots in the interior of the cells (Fig. 5a–c). Past reports suggest that these spots may be granules of organic or inorganic material38,39 called inclusion bodies. Images for samples collected over the anode at t = 24 h show cell debris and significantly damaged bacterial cells with the cell envelope ruptured (Fig. 5d–f). The TEM images reflect the regions of near-complete inactivation of the bacteria in the IVIS images (Fig. 2b) and a ~4 log decrease observed in CFU/cm2 data due to bactericidal species produced at the anode. Electrochemically generated reactive chlorine species (RCS) such as HOCl produced at the anode (Supplementary Information, Fig. S5) is known to eradicate biofilm-associated bacteria26. HOCl is a powerful oxidant and most likely kills bacteria by simultaneously damaging multiple components in the cell with evidence suggesting that the inner membrane might be the site of fatal damage22,40,41. HOCl also oxidizes cytoplasmic enzymes, such as sulfhydryl enzymes, amino acids, inhibits cell growth, protein and DNA synthesis22. Furthermore, HOCl oxidizes components of outer membrane and periplasmic proteins22,41, and has also been implicated in oxidative unfolding and aggregation of bacterial proteins42. Ultrastructure images in Fig. 5d–f show significant bacterial cell damage at the anode, including ruptured cell envelope and denatured cytoplasmic content likely from the multi-factorial damage caused by the oxidative action of RCS.

In TEM images for samples collected over the cathode, both intact bacterial cells and damaged cells were observed. Compared to the anode, at t = 24 h, IVIS images do not show any biofilm inactivity (Fig. 2b) while the TEM images show both intact bacteria and damaged bacteria. Taken together, these results suggest that while some of the bacteria were killed on cathode (Fig. 5) yet the surviving bacterial population could still saturate the IVIS activity maps.

Over both the anode and the cathode, the lysed or damaged bacteria showed increased cellular debris as compared with the control samples. Notably, cell damage at both the anode and the cathode was also accompanied with the presence of other structures within the size range ~50–150 nm (highlighted by yellow circles). It has been reported previously that the size of membrane vesicles (MVs) range from ~50–150 nm in Pseudomonas aeruginosa43 biofilms. Notably, these MV-like structures were not observed in control samples at t = 0 h, 8 h or 24 h (Figs. 35) nor at the anode or the cathode at t = 0 h and 8 h time points (Fig. 5e,h,f,i).

Electrochemical treatment of tobramycin-resistant variants

Tobramycin is an aminoglycoside antibiotic that is commonly used to resolve infections from gram-negative pathogens, such as PA11,16,44. Although antimicrobial resistance of PA biofilms is typically multi-factorial and still not fully understood45, nonetheless, the use of aminoglycosides like tobramycin has not only been linked to the development of resistance in PA biofilms by production of periplasmic glucans that can bind and sequester tobramycin before it reaches the target sites19,46 or to the expression of novel efflux pumps in the biofilms47, but in fact to the induction of the biofilm formation itself48.

In response to the in vitro tobramycin (TOB) treatment of lawn biofilms on agar, tobramycin-resistant variants emerge (Fig. 6a) in the clearance zone around the antibiotic source at approximately t = 72 h13. The electroceutical treatment was started after the TOB-resistant phenotypes were observed at t = 72 h in the clearance zone (Fig. 6a) and was carried out for the next 24 h (i.e., until t = 96 h). At t = 96 h, the tobramycin resistant colonies, which emerged between radius (r) ~10.7 mm and ~21.4 mm from the center of paper disks, were eradicated by the electroceutical treatment over the anode (Fig. 6a). In comparison, over the cathode, the TOB-resistant variants were still metabolically active (Fig. 6a) after 24 h of electroceutical treatment.

For antibiotic-resistant variants, MIC is higher than the MIC for the susceptible phenotype13,49. An analytical solution was used to estimate the TOB concentration, c(r, t), where the resistant colonies were observed. The solution for the diffusion of antibiotic in an agar plate from a finite source, such as a paper disk, can be given by27,29:

$$c(r,\,t)=\frac{m}{{h}_{0}}\frac{1}{4\pi D(t+{t}_{o})}\exp \left(-\frac{{r}^{2}}{4D(t+{t}_{o})}\right),$$
(1)

where the diffusion coefficient of TOB in agar is D and was experimentally determined50 to be 3.84 × 10−10 m2/s, m is the mass of antibiotic added to the source, $${h}_{0}$$ is the height of the agar, and r is the position coordinate relative to the center of a paper disk. Note that, in order to estimate TOB concentration, time (t) in Equation 1 is offset with a correction term to = $${r}_{o}^{2}/\text{8D}$$ to account for the presence of a finite source, i.e., paper disk with radius, ro = 3 mm, as reported previously27. Both the inner radius of the petri dish, 70 mm (inner diameter is 140 mm), and the center-to-center distance between the paper disks (35 mm) were >10 times the radius of the paper disks (3 mm) used, whereas the depth of agar layer was ~3.6 mm.

At t = 96 h, the TOB concentration (from Equation 1) was estimated to be ~13.34 μg/mL and ~7.02 μg/mL (Fig. 6b) at the inner and the outer radii enveloping tobramycin resistant colonies, i.e., at 10.7 mm and 21.4 mm, respectively. Notably, these TOB concentrations were greater than 5 μg/mL, i.e., the TOB concentration previously used13 to screen for resistant variants (see section on replica plating methods in Supplementary Information) and the MIC for the susceptible phenotype13,49. The TOB-resistant variants (active in the estimated TOB concentration range of 7.02–13.34 μg/mL) were eradicated on the anode after 24 h of electroceutical treatment (Supplementary Information, Fig. S1a), while no visible effect on the resistant variant colonies was observed on the cathode (Fig. 6a) based on IVIS imaging.

Preventing emergence of antibiotic-resistant variants

Combined electroceutical and antibiotic treatment for PA-Xen41 lawn biofilm in the incubator (37 °C and 5% CO2) showed that, after 24 h of the electroceutical treatment, antibiotic-resistant variants did not emerge at t = 72 h (Fig. 7) over the anode. In contrast, these resistant variants were observed away from the anode and over the cathode (Fig. 7).

Summary and Conclusions

Electroceutical treatment was compared both at RT and in the incubator using the time-lapse quantification of biofilm viability and bacterial luciferase activity maps of PA-Xen41 lawn biofilms. A ~4 log decrease (p < 0.01) in CFU/cm2 was observed at the anode compared to control at both RT and the incubator conditions at 48 h after the start of treatment.

TEM imaging of the ultrastructure of PA-Xen41 lawn biofilms under the electroceutical treatment in an incubator showed that the bacterial cell envelopes were damaged, likely due to the RCS generated at the anode, in samples taken above the anode at t = 24 h; while a mixture of un-damaged bacterial population and cellular debris was observed over the cathode at t = 24 h.

At the anode, electroceutical treatment eliminated the tobramycin-resistant phenotypes which appear after ~3 days of TOB treatment on the PA-Xen41 lawn biofilms; whereas no effect under IVIS imaging was discernible on the resistant phenotypes at the cathode. When the electroceutical treatment was combined with tobramycin treatment for the first 24 h, the emergence of tobramycin-resistant phenotypes was prevented at the anode.

To the authors’ knowledge, the effects of electroceutical treatment on the ultrastructure of lawn biofilms are reported for the first time. Furthermore, the electroceutical treatment as well as the prevention of tobramycin-resistant variants which may emerge during antibiotic treatment of lawn biofilms were also demonstrated. Finally, these observations provide new information on the electroceutical treatment of PA-Xen41 lawn biofilms that will help develop electroceuticals as possible treatment methodologies in the future.

References

1. 1.

Høiby, N. et al. The clinical impact of bacterial biofilms. International Journal of Oral Science 3, 55–65 (2011).

2. 2.

Bjarnsholt, T. et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair and Regeneration 16, 2–10 (2008).

3. 3.

Ammons, M. C. Anti-biofilm strategies and the need for innovations in wound care. Recent Patents on Anti-Infective Drug Discovery 5, 10–17, https://doi.org/10.2174/157489110790112581 (2009).

4. 4.

Attinger, C. & Wolcott, R. Clinically addressing biofilm in chronic wounds. Advances in Wound Care 1, 127–132 (2012).

5. 5.

James, G. A. et al. Biofilms in chronic wounds. Wound Repair and Regeneration 16, 37–44 (2008).

6. 6.

Sen, C. K. et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair and Regeneration 17, 763–771 (2009).

7. 7.

Roy, S. et al. Disposable patterned electroceutical dressing (PED-10) is safe for treatment of open clinical chronic wounds. Advances in Wound Care 8, 149–159, https://doi.org/10.1089/wound.2018.0915 (2019).

8. 8.

Spadaro, J. A., Berger, T. J., Barranco, S. D., Chapin, S. E. & Becker, R. O. Antibacterial effects of silver electrodes with weak direct current. Antimicrobial Agents and Chemotherapy 6, 637–642 (1974).

9. 9.

Bolton, L., Foleno, B., Means, B. & Petrucelli, S. Direct-current bactericidal effect on intact skin. Antimicrobial Agents and Chemotherapy 18, 137–141 (1980).

10. 10.

Niepa, T. H. R., Wang, H., Gilbert, J. L. & Ren, D. Eradication of Pseudomonas aeruginosa cells by cathodic electrochemical currents delivered with graphite electrodes. Acta Biomaterialia 50, 344–352 (2017).

11. 11.

Sultana, S. T., Call, D. R. & Beyenal, H. Eradication of Pseudomonas aeruginosa biofilms and persister cells using an electrochemical scaffold and enhanced antibiotic susceptibility. NPJ Biofilms and Microbiomes 2 (2016).

12. 12.

J Bundy, K., F Butler, M. & F Hochman, R. An investigation of the bacteriostatic properties of pure metals. Journal of Biomedical Materials Research 14, 653–663, https://doi.org/10.1002/jbm.820140511 (1980).

13. 13.

Dusane, D. et al. Complete killing of agar lawn biofilms by systematic spacing of antibiotic-loaded calcium sulfate beads. Materials 12, https://doi.org/10.3390/ma12244052 (2019).

14. 14.

Pestrak, M. J. et al. Treatment with the Pseudomonas aeruginosa glycoside hydrolase PslG combats wound infection by improving antibiotic efficacy and host innate immune activity. Antimicrobial Agents and Chemotherapy 63, e00234–00219, https://doi.org/10.1128/AAC.00234-19 (2019).

15. 15.

Lawrence, R. M., Vincent, M. I. & Kim, L. Pseudomonas aeruginosa Biofilms in Disease. Microbial Ecology 68, 1 (2014).

16. 16.

Matteo, B., Antonio, V., Antony, C., Elda, R. & Benoit, G. How to manage Pseudomonas aeruginosa infections. Drugs in Context, 1, https://doi.org/10.7573/dic.212527 (2018).

17. 17.

Bulitta, J. B. et al. Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling. Antimicrobial Agents and Chemotherapy 59, 2315, https://doi.org/10.1128/AAC.04099-14 (2015).

18. 18.

Poole, K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. Journal of Molecular Microbiology and Biotechnology 3, 255–264 (2001).

19. 19.

Mah, T. et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426, 306–310, https://doi.org/10.1038/nature02122 (2003).

20. 20.

Hoyle, B. D. & Costerton, J. W. In Progress in Drug Research (eds John A. Salmon et al.) 91-105 (Birkhäuser Basel, 1991).

21. 21.

Rowley, B. A., McKenna, J. M., Chase, G. R. & Wolcott, L. E. The influence of electrical current on an infecting microorganism in wounds. Annals of the New York Academy of Sciences 238, 543–551 (1974).

22. 22.

Gray, M. J., Wholey, W. & Jakob, U. Bacterial responses to reactive chlorine species. Annual Review of Microbiology 67, 141–160, https://doi.org/10.1146/annurev-micro-102912-142520 (2013).

23. 23.

Sandvik, E. L., McLeod, B. R., Parker, A. E. & Stewart, P. S. Direct electric current treatment under physiologic saline conditions kills Staphylococcus epidermidis biofilms via electrolytic generation of hypochlorous acid. PLoS One 8 (2013).

24. 24.

Canty, M., Luke-Marshall, N., Campagnari, A. & Ehrensberger, M. Cathodic voltage-controlled electrical stimulation of titanium for prevention of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii biofilm infections. Acta Biomaterialia 48, 451–460, https://doi.org/10.1016/j.actbio.2016.11.056 (2017).

25. 25.

Kiamco, M. M. et al. Hypochlorous-acid-generating electrochemical scaffold for treatment of wound biofilms. Scientific Reports 9, 2683, https://doi.org/10.1038/s41598-019-38968-y (2019).

26. 26.

Dusane, D. H. et al. Electroceutical treatment of Pseudomonas aeruginosa biofilms. Scientific Reports 9, 2008, https://doi.org/10.1038/s41598-018-37891-y (2019).

27. 27.

Høiby, N. et al. Formation of Pseudomonas aeruginosa inhibition zone during tobramycin disk diffusion is due to transition from planktonic to biofilm mode of growth. International Journal of Antimicrobial Agents 53, 564–573, https://doi.org/10.1016/j.ijantimicag.2018.12.015 (2019).

28. 28.

Dusane, D. H. et al. Effects of loading concentration, blood and synovial fluid on antibiotic release and anti-biofilm activity of bone cement beads. Journal of Controlled Release 248, 24–32, https://doi.org/10.1016/j.jconrel.2017.01.005 (2017).

29. 29.

Gefen, O., Chekol, B., Strahilevitz, J. & Balaban, N. Q. TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay. Scientific Reports 7, 41284–41284, https://doi.org/10.1038/srep41284 (2017).

30. 30.

Matsuo, M. et al. Genetic and transcriptomic analyses of ciprofloxacin-tolerant Staphylococcus aureus isolated by the replica plating tolerance isolation system (REPTIS). Antimicrobial Agents and Chemotherapy 63, e02019–02018, https://doi.org/10.1128/AAC.02019-18 (2019).

31. 31.

Rabkin, J. M. & Hunt, T. K. Local heat increases blood flow and oxygen tension in wounds. Archives of Surgery 122, 221–225, https://doi.org/10.1001/archsurg.1987.01400140103014 (1987).

32. 32.

McGuiness, W., Vella, E. & Harrison, D. Influence of dressing changes on wound temperature. Journal of Wound Care 13, 383–385, https://doi.org/10.12968/jowc.2004.13.9.26702 (2004).

33. 33.

Gethin, G. et al. Monitoring of pH and temperature of neuropathic diabetic and nondiabetic foot ulcers for 12 weeks: An observational study. Wound Repair and Regeneration 26, 251–256, https://doi.org/10.1111/wrr.12628 (2018).

34. 34.

Toyofuku, M. et al. Environmental factors that shape biofilm formation. Bioscience, Biotechnology, and Biochemistry 80, 7–12, https://doi.org/10.1080/09168451.2015.1058701 (2016).

35. 35.

Hoštacká, A., Čižnár, I. & Štefkovičová, M. Temperature and pH affect the production of bacterial biofilm. Folia Microbiologica 55, 75–78, https://doi.org/10.1007/s12223-010-0012-y (2010).

36. 36.

Tsuji, A., Kaneko, Y., Takahashi, K., Ogawa, M. & Goto, S. The effects of temperature and pH on the growth of eight enteric and nine glucose non-fermenting species of gram-negative rods. Microbiology and Immunology 26, 15–24, https://doi.org/10.1111/j.1348-0421.1982.tb00149.x (1982).

37. 37.

Hunter, R. C. & Beveridge, T. J. High-resolution visualization of Pseudomonas aeruginosa PAO1 biofilms by freeze-substitution transmission electron microscopy. Journal of Bacteriology 187, 7619–7630 (2005).

38. 38.

Willey, J. M., Sherwood, L., Woolverton, C. J. & Prescott, L. M. Prescott’s Microbiology. (2017).

39. 39.

Pompilio, A. et al. Electrochemically synthesized silver nanoparticles are active against planktonic and biofilm cells of Pseudomonas aeruginosa and other cystic fibrosis-associated bacterial pathogens. Frontiers in Microbiology 9, https://doi.org/10.3389/fmicb.2018.01349 (2018).

40. 40.

Barrette, W. C., Hannum, D. M., Wheeler, W. D. & Hurst, J. K. General mechanism for the bacterial toxicity of hypochlorous acid: abolition of ATP production. Biochemistry 28, 9172–9178, https://doi.org/10.1021/bi00449a032 (1989).

41. 41.

Rosen, H. et al. Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils. Proceedings of the National Academy of Sciences 106, 18686, https://doi.org/10.1073/pnas.0909464106 (2009).

42. 42.

Winter, J., Ilbert, M., Graf, P. C. F., Özcelik, D. & Jakob, U. Bleach activates a redox-regulated chaperone by oxidative protein unfolding. Cell 135, 691–701, https://doi.org/10.1016/j.cell.2008.09.024 (2008).

43. 43.

Schooling, S. R. & Beveridge, T. J. Membrane vesicles: an overlooked component of the matrices of biofilms. Journal of Bacteriology 188, 5945, https://doi.org/10.1128/JB.00257-06 (2006).

44. 44.

Tseng, B. S. et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environmental Microbiology 15, 2865–2878, https://doi.org/10.1111/1462-2920.12155 (2013).

45. 45.

Poole, K. Pseudomonas aeruginosa: resistance to the max. Frontiers in Microbiology 2, 65–65, https://doi.org/10.3389/fmicb.2011.00065 (2011).

46. 46.

Sadovskaya, I. et al. High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: the ndvB gene is involved in the production of highly glycerol-phosphorylated β-(1→3)-glucans, which bind aminoglycosides. Glycobiology 20, 895–904, https://doi.org/10.1093/glycob/cwq047 (2010).

47. 47.

Zhang, J., Jiang, R., Wang, W., Takayama, H. & Tanaka, Y. Apoptosis are induced in J774 macrophages upon phagocytosis and killing of Pseudomonas aeruginosa. Cellular Immunology 286, 11–15, https://doi.org/10.1016/j.cellimm.2013.10.006 (2013).

48. 48.

Hoffman, L. R. et al. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436, 1171–1175, https://doi.org/10.1038/nature03912 (2005).

49. 49.

Brauner, A., Fridman, O., Gefen, O. & Balaban, N. Q. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nature Reviews Microbiology 14, 320, https://doi.org/10.1038/nrmicro.2016.34 (2016).

50. 50.

Nichols, W. W., Dorrington, S. M., Slack, M. P. & Walmsley, H. L. Inhibition of tobramycin diffusion by binding to alginate. Antimicrobial Agents and Chemotherapy 32, 518, https://doi.org/10.1128/AAC.32.4.518 (1988).

Acknowledgements

Support from The Ohio State University Infectious Disease Institute (IDI), Discovery Themes and Public Health Preparedness for Infectious Disease (PHPID) Transdisciplinary Team Grant, Departments of Microbial Infection and Immunity, Mechanical and Aerospace Engineering, and The Center for Regenerative Medicine and Cell-Based Therapies, is gratefully acknowledged. (SP & PS). Images presented in this report were generated using the instruments and services at the Campus Microscopy and Imaging Facility, The Ohio State University. This facility is supported in part by grant P30 CA016058, National Cancer Institute, Bethesda, MD. We also acknowledge partial personnel support from the US Army Research Office through grant number W911NF-16-1-0278 (SP), R01 NIH-GM124436 (PS), and R01AI143916 (DW).

Author information

Authors

Contributions

Shaurya Prakash, Vish V. Subramaniam, Paul Stoodley, and Daniel J. Wozniak conceptualized the experiments and provided supervision for the reported study. Biofilm viability and activity data was recorded and analyzed by Varun Lochab and Travis H. Jones, with support from Casey W. Peters for comparisons between the treatment in incubator and at room temperature. Varun Lochab performed ultrastructure imaging of Pseudomonas aeruginosa lawn biofilms and experiments on the antibiotic-resistant variants. Paul Stoodley and Devendra H. Dusane supervised the methodology for experiments on antibiotic resistant variants. Varun Lochab and Shaurya Prakash wrote the manuscript while all other authors reviewed and edited the manuscript. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Shaurya Prakash.

Ethics declarations

Competing interests

The authors declare no competing interests.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

Lochab, V., Jones, T.H., Dusane, D.H. et al. Ultrastructure imaging of Pseudomonas aeruginosa lawn biofilms and eradication of the tobramycin-resistant variants under in vitro electroceutical treatment. Sci Rep 10, 9879 (2020). https://doi.org/10.1038/s41598-020-66823-y